Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03836209
Title Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors PrECOG, LLC.
Indications

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin + Gilteritinib

Cytarabine + Daunorubicin + Midostaurin

Cytarabine

Midostaurin

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST